110 related articles for article (PubMed ID: 38517251)
81. Structure-based pharmacophore modeling, virtual screening, and molecular dynamics simulation studies for identification of
Oduselu GO; Afolabi R; Ademuwagun I; Vaughan A; Adebiyi E
Front Med (Lausanne); 2022; 9():1022429. PubMed ID: 36714108
[No Abstract] [Full Text] [Related]
82. Evaluating the suitability of RNA intervention mechanism exerted by some flavonoid molecules against dengue virus MTase RNA capping site: a molecular docking, molecular dynamics simulation, and binding free energy study.
Manjula S; Kumaradhas P
J Biomol Struct Dyn; 2020 Aug; 38(12):3533-3543. PubMed ID: 31514688
[TBL] [Abstract][Full Text] [Related]
83. Computational investigation of
Yousaf MA; Anwer SA; Basheera S; Sivanandan S
J Biomol Struct Dyn; 2024; 42(4):1901-1923. PubMed ID: 37154824
[TBL] [Abstract][Full Text] [Related]
84. Aphrodisiac Performance of Bioactive Compounds from
Palanichamy C; Pavadai P; Panneerselvam T; Arunachalam S; Babkiewicz E; Ram Kumar Pandian S; Shanmugampillai Jeyarajaguru K; Nayak Ammunje D; Kannan S; Chandrasekaran J; Sundar K; Maszczyk P; Kunjiappan S
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744923
[TBL] [Abstract][Full Text] [Related]
85. Lead optimization of
Ojo OA; Adegboyega AE; Taiwo OA; Olowosoke CB; Johnson GI; Umedum NL; Onuh K; Adeduro MN; Nwobodo VO; Elekan AO; Alemika TE; Johnson TO
J Biomol Struct Dyn; 2023 Dec; ():1-15. PubMed ID: 38109128
[TBL] [Abstract][Full Text] [Related]
86. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
Kaushik S; Dar L; Kaushik S; Yadav JP
J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
[TBL] [Abstract][Full Text] [Related]
87. Combined study of docking and molecular dynamics against DNV-3 SN1 protein by bixinoids.
da Fonseca AM; Soares NB; Meirú MIL; Colares RP; Neto MM; Sobrinho ACN; Dos Santos HS; Marinho ES
J Biomol Struct Dyn; 2023 Jul; 41(10):4549-4559. PubMed ID: 35510585
[TBL] [Abstract][Full Text] [Related]
88. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
[TBL] [Abstract][Full Text] [Related]
89. Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors.
Poola AA; Prabhu PS; Murthy TPK; Murahari M; Krishna S; Samantaray M; Ramaswamy A
Front Mol Biosci; 2023; 10():1106128. PubMed ID: 36911525
[TBL] [Abstract][Full Text] [Related]
90. Hit-to-Lead Short Peptides against Dengue Type 2 Envelope Protein: Computational and Experimental Investigations.
Zaidi NJ; Abdullah AA; Heh CH; Lin CH; Othman R; Ahmad Fuaad AAH
Molecules; 2022 May; 27(10):. PubMed ID: 35630712
[TBL] [Abstract][Full Text] [Related]
91. In silico discovery of food-derived phytochemicals against asialoglycoprotein receptor 1 for treatment of hypercholesterolemia: Pharmacophore modeling, molecular docking and molecular dynamics simulation approach.
Gao S; Wang L; Bai F; Xu S
J Mol Graph Model; 2023 Dec; 125():108614. PubMed ID: 37651861
[TBL] [Abstract][Full Text] [Related]
92. Deciphering
Alghamdi MA; Azam F; Alam P
J Biomol Struct Dyn; 2024 Jan; ():1-17. PubMed ID: 38230450
[TBL] [Abstract][Full Text] [Related]
93. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
[TBL] [Abstract][Full Text] [Related]
94. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
Purohit P; Barik D; Agasti S; Panda M; Meher BR
J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
[TBL] [Abstract][Full Text] [Related]
95. Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics.
Tanbin S; Ahmad Fuad FA; Abdul Hamid AA
BioTech (Basel); 2020 Dec; 10(1):. PubMed ID: 35822774
[TBL] [Abstract][Full Text] [Related]
96. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
97. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
Aarthy M; Singh SK
Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
[TBL] [Abstract][Full Text] [Related]
98. Advances in Computational Methods to Discover New NS2B-NS3 Inhibitors Useful Against Dengue and Zika Viruses.
Dos Santos Nascimento IJ; da Silva Rodrigues ÉE; da Silva MF; de Araújo-Júnior JX; de Moura RO
Curr Top Med Chem; 2022; 22(29):2435-2462. PubMed ID: 36415099
[TBL] [Abstract][Full Text] [Related]
99. Targeting human inosine 5' monophosphate dehydrogenase type 2 for anti-dengue lead identification - a computational approach.
Kesavan LR; Kamalan BC; Sivanandan S
J Biomol Struct Dyn; 2024 Mar; ():1-15. PubMed ID: 38517251
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
